According to a new study, a chemical compound named BAM15, mitochondrial uncoupler, can prevent sarcopenic obesity, or age-related muscle loss accompanied by an increase in fat tissue.
The findings of the research were published in the 'Journal of Cachexia, Sarcopenia and Muscle' by Wagner Dantas, PhD, a Postdoctoral Researcher in Kirwan's Integrated Physiology and Molecular Medicine Laboratory as the lead author and Axelrod and Kirwan as corresponding authors.
The researchers discovered compounds that helped older obese mice lose fat and weight, build muscle and strength, reduce age-related inflammation, and increase physical activity.
"Loss of muscle mass is typically not a concern in younger adults with obesity. However, as people age, that changes. Older adults with sarcopenic obesity suffer accelerated muscle loss. They become less active. As a result, they are at high risk for falls, stroke, heart disease, poorer quality of life and premature death," said Christopher Axelrod.
The weakness and frailty common to sarcopenic obesity are offset in older mice -- the equivalent of aged 60-65 in human years -- given BAM15. The mice, all of whom had obesity, were fed high-fat diets. Despite that, the mice given BAM15 lost weight and got stronger and more active.
"Typically, when you lose weight, you also lose muscle, and in some circumstances, you can lose a lot of it," Axelrod said. "In this study, the aged mice increased their muscle mass by an average of 8 per cent, their strength by 40 per cent, while they lost more than 20 per cent of their fat."
BAM15 works by making the mitochondria, the power plants of the cell, less efficient. The result is that the mitochondria burn more energy. The researchers are reluctant to describe BAM15 as a miracle drug. More research will be needed to determine its effectiveness for people.
However, the findings of BAM15 have important implications for improving the quality of life for older adults, especially for the rapidly growing number of people with obesity. Preventing, delaying, or reversing the causes and consequences of sarcopenic obesity may allow people to live longer and healthier lives.
"These data highlight that mitochondrial uncouplers may play an important role in improving healthspan -- the time a person enjoys good health -- in advanced age," said Pennington Biomedical Executive Director John Kirwan, PhD.
BAM15 improves many of the key determinants of health and ageing which include removing damaged mitochondria, making more healthy mitochondria, and reducing "inflammaging," or age-related inflammation, linked to muscle loss.
"Extending health span is even more important than extending lifespan," Kirwan said. "Suppose you could add 20 or 30 years to a person's life. What would be the point if their quality of life was awful?" (ANI)